166 related articles for article (PubMed ID: 21145039)
1. Proton magnetic resonance spectroscopy and illness stage in schizophrenia--a systematic review and meta-analysis.
Brugger S; Davis JM; Leucht S; Stone JM
Biol Psychiatry; 2011 Mar; 69(5):495-503. PubMed ID: 21145039
[TBL] [Abstract][Full Text] [Related]
2. Proton Magnetic Resonance Spectroscopy of N-acetyl Aspartate in Chronic Schizophrenia, First Episode of Psychosis and High-Risk of Psychosis: A Systematic Review and Meta-Analysis.
Whitehurst TS; Osugo M; Townsend L; Shatalina E; Vava R; Onwordi EC; Howes O
Neurosci Biobehav Rev; 2020 Dec; 119():255-267. PubMed ID: 33068555
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients].
Szulc A; Galińska B; Tarasów E; Walecki J; Dzienis W; Kubas B; Czernikiewicz A
Psychiatr Pol; 2003; 37(6):977-88. PubMed ID: 14727370
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients].
Başoğlu C; Cetin M; Oner O; Ebrinç S; Semiz UB; Kandilcioğlu H; Silit E; Kizilkaya E
Turk Psikiyatri Derg; 2006; 17(2):85-91. PubMed ID: 16755408
[TBL] [Abstract][Full Text] [Related]
5. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
Szulc A; Galinska B; Tarasow E; Dzienis W; Kubas B; Konarzewska B; Walecki J; Alathiaki AS; Czernikiewicz A
Pharmacopsychiatry; 2005 Sep; 38(5):214-9. PubMed ID: 16189748
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy (H-MRS) studies of schizophrenia.
Rowland L; Bustillo JR; Lauriello J
Semin Clin Neuropsychiatry; 2001 Apr; 6(2):121-30. PubMed ID: 11296312
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
Jessen F; Scherk H; Träber F; Theyson S; Berning J; Tepest R; Falkai P; Schild HH; Maier W; Wagner M; Block W
Schizophr Res; 2006 Oct; 87(1-3):81-8. PubMed ID: 16842971
[TBL] [Abstract][Full Text] [Related]
8. Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect.
Heimberg C; Komoroski RA; Lawson WB; Cardwell D; Karson CN
Psychiatry Res; 1998 Aug; 83(2):105-15. PubMed ID: 9818736
[TBL] [Abstract][Full Text] [Related]
9. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
Théberge J; Al-Semaan Y; Drost DJ; Malla AK; Neufeld RW; Bartha R; Manchanda R; Menon R; Densmore M; Schaefer B; Williamson PC
Psychiatry Res; 2004 Jul; 131(2):107-14. PubMed ID: 15313517
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia.
Cecil KM; Lenkinski RE; Gur RE; Gur RC
Neuropsychopharmacology; 1999 Feb; 20(2):131-40. PubMed ID: 9885793
[TBL] [Abstract][Full Text] [Related]
11. Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls.
Steel RM; Bastin ME; McConnell S; Marshall I; Cunningham-Owens DG; Lawrie SM; Johnstone EC; Best JJ
Psychiatry Res; 2001 May; 106(3):161-70. PubMed ID: 11382538
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
Szulc A; Galinska B; Tarasow E; Waszkiewicz N; Konarzewska B; Poplawska R; Bibulowicz D; Simonienko K; Walecki J
Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
[TBL] [Abstract][Full Text] [Related]
14. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
Wood SJ; Berger GE; Lambert M; Conus P; Velakoulis D; Stuart GW; Desmond P; McGorry PD; Pantelis C
Arch Gen Psychiatry; 2006 Sep; 63(9):969-76. PubMed ID: 16952999
[TBL] [Abstract][Full Text] [Related]
15. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis.
Steen RG; Hamer RM; Lieberman JA
Neuropsychopharmacology; 2005 Nov; 30(11):1949-62. PubMed ID: 16123764
[TBL] [Abstract][Full Text] [Related]
16. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J
Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
[TBL] [Abstract][Full Text] [Related]
17. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy of the frontal lobe in schizophrenics: a critical review of the methodology.
Sanches RF; Crippa JA; Hallak JE; Araújo D; Zuardi AW
Rev Hosp Clin Fac Med Sao Paulo; 2004 Jun; 59(3):145-52. PubMed ID: 15286836
[TBL] [Abstract][Full Text] [Related]
19. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T
Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
[TBL] [Abstract][Full Text] [Related]
20. A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naïve and early-treated first episode psychosis.
Wood SJ; Berger GE; Wellard RM; Proffitt T; McConchie M; Velakoulis D; McGorry PD; Pantelis C
Schizophr Res; 2008 Jul; 102(1-3):163-70. PubMed ID: 18456460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
